TapewireFind a company

person · Reporting owner

KIDDER C ROBERT

Disclosed activity across 4 companies

Tapewire entity
12276
SEC CIK
0001179703

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ADVANCED DRAINAGE SYSTEMS, INC.WMS · Entity 2328DirectorJuly 22, 2021July 26, 2021
Cohn Robbins Holdings Corp.CRHC · Entity 122096DirectorSeptember 08, 2020September 08, 2020
MORGAN STANLEYMS · Entity 2815DirectorMay 13, 2014May 15, 2014
Merck & Co., Inc.MRK · Entity 2807DirectorMay 12, 2017May 12, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ADVANCED DRAINAGE SYSTEMS, INC.

Report date July 22, 2021 · Filed July 26, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect34,680 Reported balance After 2021-07-22 transaction · row 1
1 source row

Row 1 · 2021-07-22 · Grant · Acquired 1,334 · Balance 34,680

Common StockSEC Table I · non-derivativeIndirectBy Trust4,000 Reported balance Holding disclosure · report date 2021-07-22 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 4,000

Cohn Robbins Holdings Corp.

Report date September 08, 2020 · Filed September 08, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class B ordinary sharesSEC Table II · derivative / convertible securityDirectNot disclosed Reported balance Holding disclosure · report date 2020-09-08 · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · Balance Not disclosed

F1: As described in the issuer's registration statement on Form S-1 (File No. 333-240277) under the heading "Description of Securities-Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: As described in the issuer's registration statement on Form S-1 (File No. 333-240277) under the heading "Description of Securities-Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date.

MORGAN STANLEY

Report date May 13, 2014 · Filed May 15, 2014

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect158,731.441 Reported balance After 2014-05-13 transaction · row 1
1 source row

Row 1 · 2014-05-13 · Grant · Acquired 8,218.818 · Balance 158,731.441

F1: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.

Merck & Co., Inc.

Report date May 12, 2017 · Filed May 12, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect9,317 Ending reported balance After 2017-05-12 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2017-05-12 · Exercise / conversion · Acquired 5,000 · Balance 14,317

Row 2 · 2017-05-12 · Sale · Disposed 5,000 · Balance 9,317

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $35.19 · Expires 2020-08-03Direct0 Reported balance After 2017-05-12 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2017-05-12 · Exercise / conversion · Disposed 5,000 · Balance 0

F1: The option became exercisable in equal installments on 8/4/2011, 8/4/2012 and 8/4/2013.

Common StockSEC Table I · non-derivativeIndirectBy Trust1,022 Reported balance Holding disclosure · report date 2017-05-12 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 1,022

Filing footnotes · ownership attribution and instrument terms

F1: The option became exercisable in equal installments on 8/4/2011, 8/4/2012 and 8/4/2013.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 22, 2021 Filed Jul 26, 2021 18:16 UTC ADVANCED DRAINAGE SYSTEMS, INC. WMS · Entity 2328 GrantCommon Stock 1,334 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-029945 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,680

Read SEC document
July 23, 2020 Filed Jul 27, 2020 18:00 UTC ADVANCED DRAINAGE SYSTEMS, INC. WMS · Entity 2328 GrantCommon Stock 2,647 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-020484 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,346

Read SEC document
July 23, 2019 Filed Jul 25, 2019 16:31 UTC ADVANCED DRAINAGE SYSTEMS, INC. WMS · Entity 2328 GrantCommon Stock 3,993 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-020409 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,699

Read SEC document
July 24, 2018 Filed Jul 26, 2018 18:02 UTC ADVANCED DRAINAGE SYSTEMS, INC. WMS · Entity 2328 GrantCommon Stock 2,632 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-020692 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,706

Read SEC document
September 15, 2017 Filed Sep 18, 2017 18:42 UTC ADVANCED DRAINAGE SYSTEMS, INC. WMS · Entity 2328 GrantCommon Stock 3,731 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-022241 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,074

Read SEC document
May 12, 2017 Filed May 12, 2017 20:58 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $35.19 $0.00
Disclosure

SEC source: 0001225208-17-009615 · doc4.xml · derivative · entry 4

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2020-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option became exercisable in equal installments on 8/4/2011, 8/4/2012 and 8/4/2013.

Read SEC document
May 12, 2017 Filed May 12, 2017 20:58 UTC Merck & Co., Inc. MRK · Entity 2807 SaleCommon Stock 5,000 $63.54 $317,695.00
Disclosure

SEC source: 0001225208-17-009615 · doc4.xml · nonDerivative · entry 2

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,317

Read SEC document
May 12, 2017 Filed May 12, 2017 20:58 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 5,000 $35.19 $175,950.00
Disclosure

SEC source: 0001225208-17-009615 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,317

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 08, 2017 Filed Feb 10, 2017 17:45 UTC ADVANCED DRAINAGE SYSTEMS, INC. WMS · Entity 2328 GrantCommon Stock 6,199 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-003563 · doc4.xml · nonDerivative · entry 2

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,343

Read SEC document
February 08, 2017 Filed Feb 10, 2017 17:45 UTC ADVANCED DRAINAGE SYSTEMS, INC. WMS · Entity 2328 GrantCommon Stock 6,199 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-003563 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,144

Read SEC document
May 27, 2016 Filed May 31, 2016 19:56 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 3,009.915 $56.48 $170,000.00
Disclosure

SEC source: 0001225208-16-034168 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,408.591

Underlying: Common Stock · 3,009.915 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 29, 2015 Filed Jun 1, 2015 18:50 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 2,463.4587 $60.89 $150,000.00
Disclosure

SEC source: 0001225208-15-013061 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,686.6497

Underlying: Common Stock · 2,463.4587 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 30, 2014 Filed Jun 3, 2014 17:01 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 2,592.4646 $57.86 $150,000.00
Disclosure

SEC source: 0001225208-14-014282 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,684.4106

Underlying: Common Stock · 2,592.4646 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 13, 2014 Filed May 15, 2014 17:50 UTC MORGAN STANLEY MS · Entity 2815 GrantCommon Stock 8,218.818 $0.00 $0.00
Disclosure

SEC source: 0001209191-14-034331 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,731.441

F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.

Read SEC document
May 31, 2013 Filed Jun 3, 2013 19:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 3,211.9914 $46.70 $150,000.00
Disclosure

SEC source: 0001225208-13-013651 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,577.1374

Underlying: Common Stock · 3,211.9914 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 14, 2013 Filed May 16, 2013 17:02 UTC MORGAN STANLEY MS · Entity 2815 GrantCommon Stock 10,301.08 $0.00 $0.00
Disclosure

SEC source: 0001209191-13-026897 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,039.304

F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.

Read SEC document
May 25, 2012 Filed May 29, 2012 19:22 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 3,994.6738 $37.55 $150,000.00
Disclosure

SEC source: 0001225208-12-013302 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,935.0308

Underlying: Common Stock · 3,994.6738 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 15, 2012 Filed May 17, 2012 17:14 UTC MORGAN STANLEY MS · Entity 2815 GrantCommon Stock 17,499.773 $0.00 $0.00
Disclosure

SEC source: 0001209191-12-028971 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,189.593

F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.

Read SEC document
May 27, 2011 Filed May 31, 2011 14:44 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 4,142.5021 $36.21 $150,000.00
Disclosure

SEC source: 0001225208-11-015339 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,641.0561

Underlying: Common Stock · 4,142.5021 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 18, 2011 Filed May 20, 2011 18:27 UTC MORGAN STANLEY MS · Entity 2815 GrantCommon Stock 10,248.59 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-030168 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,075.56

F1 · kind: Restricted stock units granted under the Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.

Read SEC document
August 04, 2010 Filed Aug 6, 2010 14:54 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $35.19 $0.00
Disclosure

SEC source: 0001225208-10-018703 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2020-08-03

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning August 4, 2011.

Read SEC document
May 28, 2010 Filed Jun 1, 2010 19:59 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 1,632.5319 $33.69 $55,000.00
Disclosure

SEC source: 0001225208-10-014285 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,395.0719

Underlying: Common Stock · 1,632.5319 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 18, 2010 Filed May 20, 2010 17:26 UTC MORGAN STANLEY MS · Entity 2815 GrantCommon Stock 9,282.672 $0.00 $0.00
Disclosure

SEC source: 0001209191-10-029399 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,489.091

F1 · kind: Restricted stock units granted under the Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 20:03 UTC Merck & Co., Inc. MRK · Entity 2807 Disposition to issuerPhantom Stock · Derivative 8,182.63 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-09-021837 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,182.63 shares

Expires not disclosed

F3 · derivative.exercise_price: Each unit was the economic equivalent of one share of Schering-Plough Corporation common stock.

F4 · price: In connection with the Transactions, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.

F4 · derivative.exercise_date: In connection with the Transactions, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.

F4 · derivative.expiration_date: In connection with the Transactions, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 20:03 UTC Merck & Co., Inc. MRK · Entity 2807 GrantCommon Stock 1,022 $0.00 $0.00
Disclosure

SEC source: 0001225208-09-021837 · doc4.xml · nonDerivative · entry 2

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 1,022

F2 · price: Pursuant to the Merger Agreement, each share of common stock of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) was converted to an equal number of shares of New Merck.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 20:03 UTC Merck & Co., Inc. MRK · Entity 2807 Disposition to issuerCommon Stock 6,840 $0.00 $0.00
Disclosure

SEC source: 0001225208-09-021837 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,318

F1 · price: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") by and among, inter alia, Merck & Co., Inc., formerly Schering-Plough Corporation, ("New Merck") and Merck Sharp & Dohme Corp., formerly Merck & Co., Inc., and upon the completion of the transactions contemplated therein (the "Transactions"), each common share of Schering-Plough Corporation common stock was converted into 0.5767 shares of New Merck common stock and $10.50 in cash. Any fractional share holdings were paid in cash pursuant to a formula in the Merger Agreement.

Read SEC document
November 03, 2009 Filed Dec 17, 2009 16:51 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 747.2123 $30.67 Strike: $0.00 $22,917.00
Disclosure

SEC source: 0001225208-09-024625 · doc4.xml · derivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 747.2123

Underlying: Common Stock · 747.2123 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Read SEC document
June 01, 2009 Filed Jun 2, 2009 16:33 UTC Merck & Co., Inc. SGP · Entity 2807 GrantCommon Shares 1,567 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-09-000073 · kid736.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,158

F1 · security: Shares acquired pursuant to the Directors Compensation Plan.

F2 · price: Not Applicable.

Read SEC document
April 29, 2009 Filed May 1, 2009 16:45 UTC MORGAN STANLEY MS · Entity 2815 GrantCommon Stock 11,116.051 $0.00 $0.00
Disclosure

SEC source: 0001209191-09-023779 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,874.127

F1 · kind: 5,558.051 deferred stock units and 5,558 shares of common stock acquired under the Morgan Stanley Directors' Equity Capital Accumulation Plan. Deferred stock units are convertible into shares of common stock at a ratio of 1 to 1.

Read SEC document
December 01, 2008 Filed Dec 1, 2008 22:45 UTC Merck & Co., Inc. SGP · Entity 2807 GrantCommon Shares 2,567 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-08-000096 · kid686.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,591

F1 · security: Shares acquired pursuant to the Directors Compensation Plan.

F2 · price: Not Applicable.

Read SEC document
May 30, 2008 Filed May 30, 2008 21:25 UTC Merck & Co., Inc. SGP · Entity 2807 GrantCommon Shares 1,680 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-08-000058 · kid673.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,024

F1 · security: Shares acquired pursuant to the Directors Compensation Plan.

F2 · price: Not Applicable.

Read SEC document
April 08, 2008 Filed Apr 10, 2008 17:51 UTC MORGAN STANLEY MS · Entity 2815 GrantCommon Stock 5,230.84 $0.00 $0.00
Disclosure

SEC source: 0001209191-08-023746 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,613.586

F1 · kind: 2,615.84 Stock Units and 2,615 shares of Common Stock acquired under the Morgan Stanley Directors' Equity Capital Accumulation Plan. Stock Units are convertible into shares of Common Stock at a ratio of 1 to 1.

Read SEC document
December 20, 2007 Filed Dec 21, 2007 17:01 UTC MORGAN STANLEY MS · Entity 2815 Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 3,153 $0.00 Strike: $33.27 $0.00
Disclosure

SEC source: 0001209191-07-071504 · doc4.xml · derivative · entry 4

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,153 shares

Expires 2008-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Reflects the application of a mandatory anti-dilution adjustment to the Reporting Person's Stock Units and Stock Options as a result of the issuer's spin-off of Discover Financial Services on June 30, 2007.

F1 · shares: Reflects the application of a mandatory anti-dilution adjustment to the Reporting Person's Stock Units and Stock Options as a result of the issuer's spin-off of Discover Financial Services on June 30, 2007.

Read SEC document
December 20, 2007 Filed Dec 21, 2007 17:01 UTC MORGAN STANLEY MS · Entity 2815 Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 9,399 $0.00 Strike: $32.64 $0.00
Disclosure

SEC source: 0001209191-07-071504 · doc4.xml · derivative · entry 3

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,399 shares

Expires 2008-03-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Reflects the application of a mandatory anti-dilution adjustment to the Reporting Person's Stock Units and Stock Options as a result of the issuer's spin-off of Discover Financial Services on June 30, 2007.

F1 · shares: Reflects the application of a mandatory anti-dilution adjustment to the Reporting Person's Stock Units and Stock Options as a result of the issuer's spin-off of Discover Financial Services on June 30, 2007.

Read SEC document
December 20, 2007 Filed Dec 21, 2007 17:01 UTC MORGAN STANLEY MS · Entity 2815 Exercise / conversionCommon Stock 3,153 $33.27 $104,900.31
Disclosure

SEC source: 0001209191-07-071504 · doc4.xml · nonDerivative · entry 2

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,239.66

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 20, 2007 Filed Dec 21, 2007 17:01 UTC MORGAN STANLEY MS · Entity 2815 Exercise / conversionCommon Stock 9,399 $32.64 $306,783.36
Disclosure

SEC source: 0001209191-07-071504 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,086.66

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the application of a mandatory anti-dilution adjustment to the Reporting Person's Stock Units and Stock Options as a result of the issuer's spin-off of Discover Financial Services on June 30, 2007.

Read SEC document
December 01, 2007 Filed Dec 4, 2007 21:49 UTC Merck & Co., Inc. SGP · Entity 2807 GrantCommon Shares 1,064 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-07-000083 · kid634.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,344

F1 · security: Shares acquired pursuant to the Directors Compensation Plan.

F2 · price: Not Applicable.

Read SEC document
June 01, 2007 Filed Jun 4, 2007 20:45 UTC Merck & Co., Inc. SGP · Entity 2807 GrantCommon Shares 1,018 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-07-000055 · kid621.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,280

F1 · security: Shares acquired pursuant to the Directors Compensation Plan.

F2 · price: Not Applicable.

Read SEC document
April 10, 2007 Filed Apr 12, 2007 16:53 UTC MORGAN STANLEY MS · Entity 2815 GrantCommon Stock 3,102.525 $0.00 $0.00
Disclosure

SEC source: 0001209191-07-023716 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,624.383

F1 · kind: 1,551.525 Stock Units acquired under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1; and 1,551 shares of Common Stock.

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · derivative · entry 14

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2007-05-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 100 $80.67 $8,067.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 13

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,456.816

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 700 $80.66 $56,462.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 12

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,556.816

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 600 $80.69 $48,414.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 11

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,256.816

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 300 $80.70 $24,210.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 10

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,856.816

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 500 $80.68 $40,340.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 9

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,156.816

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 600 $80.71 $48,426.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 8

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,656.816

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 400 $80.72 $32,288.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 7

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,256.816

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 1,200 $80.73 $96,876.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 6

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,656.816

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 2,600 $80.74 $209,924.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 5

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,856.816

Read SEC document
January 05, 2007 Filed Jan 8, 2007 17:44 UTC MORGAN STANLEY MS · Entity 2815 SaleCommon Stock 700 $80.75 $56,525.00
Disclosure

SEC source: 0001209191-07-002706 · doc4.xml · nonDerivative · entry 4

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,456.816

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.